Concepedia

Author

Lara Paracchini

Mario Negri Institute for Pharmacological ResearchORCID

Also Known As

L Paracchini, L. Paracchini, Lara Paracchini, Lara, Paracchini, Paracchini, Lara

123

Publications

1.1K

Citations

18

H-Index

32

Concepts

All Affiliations

Mario Negri Institute for Pharmacological ResearchUniversity of PaduaIstituti di Ricovero e Cura a Carattere ScientificoUniversity of Milano-BicoccaUniversity of Brescia
LP

About

Lara Paracchini is an author at Mario Negri Institute for Pharmacological Research specializing in medicine, pathology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

494

2

Cell Biology

3

3

90

3

Immunology

1

1

180

4

Neurology

1

1

180

5

Neuroscience

1

1

180

Lara Paracchini

×

22

Publications

1.1K

Citations

18

H-Index

YearCitations

Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy

Valentina Iori, Anand M. Iyer, Teresa Ravizza,

Neurobiology of Disease

2016

180

Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models

Cristina Belgiovine, Ezia Bello, Manuela Liguori,

British Journal of Cancer

2017

149

Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts

Paola Todeschini, Elisa Salviato, Lara Paracchini,

Cancer Letters

2016

82

Protection of Brain Injury by Amniotic Mesenchymal Stromal Cell-Secreted Metabolites

Francesca Pischiutta, Laura Brunelli, Pietro Romele,

Critical Care Medicine

2016

75

miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities

Enrica Calura, Robert Fruscio, Lara Paracchini,

Clinical Cancer Research

2013

74

lncRNAs as Novel Indicators of Patients' Prognosis in Stage I Epithelial Ovarian Cancer: A Retrospective and Multicentric Study

Paolo Martini, Lara Paracchini, Giulia Caratti,

Clinical Cancer Research

2016

66

Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies

Marco Petrillo, Gian Franco Zannoni, Luca Beltrame,

Annals of Oncology

2016

61

Antiangiogenic activity of trabectedin in myxoid liposarcoma: Involvement of host TIMP‐1 and TIMP‐2 and tumor thrombospondin‐1

Romina Dossi, Roberta Frapolli, Silvana Di Giandomenico,

International Journal of Cancer

2014

57

Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study

Luca Beltrame, Mariacristina Di Marino, Robert Fruscio,

Annals of Oncology

2015

55

Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer

Lara Paracchini, Luca Beltrame, Tommaso Grassi,

Clinical Cancer Research

2020

52

Page 1